| Literature DB >> 25762659 |
Anne Biever1, Emma Puighermanal1, Akinori Nishi2, Alexandre David1, Claire Panciatici1, Sophie Longueville3, Dimitris Xirodimas4, Giuseppe Gangarossa1, Oded Meyuhas5, Denis Hervé3, Jean-Antoine Girault3, Emmanuel Valjent6.
Abstract
Ribosomal protein S6 (rpS6), a component of the 40S ribosomal subunit, is phosphorylated on several residues in response to numerous stimuli. Although commonly used as a marker for neuronal activity, its upstream mechanisms of regulation are poorly studied and its role in protein synthesis remains largely debated. Here, we demonstrate that the psychostimulant d-amphetamine (d-amph) markedly increases rpS6 phosphorylation at Ser235/236 sites in both crude and synaptoneurosomal preparations of the mouse striatum. This effect occurs selectively in D1R-expressing medium-sized spiny neurons (MSNs) and requires the cAMP/PKA/DARPP-32/PP-1 cascade, whereas it is independent of mTORC1/p70S6K, PKC, and ERK signaling. By developing a novel assay to label nascent peptidic chains, we show that the rpS6 phosphorylation induced in striatonigral MSNs by d-amph, as well as in striatopallidal MSNs by the antipsychotic haloperidol or in both subtypes by papaverine, is not correlated with the translation of global or 5' terminal oligopyrimidine tract mRNAs. Together, these results provide novel mechanistic insights into the in vivo regulation of the post-translational modification of rpS6 in the striatum and point out the lack of a relationship between PKA-dependent rpS6 phosphorylation and translation efficiency.Entities:
Keywords: d-amphetamine; dopamine; protein synthesis; ribosomal protein S6; striatum
Mesh:
Substances:
Year: 2015 PMID: 25762659 PMCID: PMC6605295 DOI: 10.1523/JNEUROSCI.3288-14.2015
Source DB: PubMed Journal: J Neurosci ISSN: 0270-6474 Impact factor: 6.167